Research Trial for Moderate to Severe Eczema (81 Weeks)

For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis

Research Trial for Moderate to Severe Eczema (81 Weeks)

Study Summary

Who Can Participate?
Adults aged 18+ with moderate to severe eczema (atopic dermatitis) may be eligible to participate.

Inclusion Criteria

  • Chronic eczema with symptoms for at least 1 year
  • Eczema affecting an area equal to 10 hand prints or more
  • Tried eczema treatments in the last 6 months (topical) or 12 months (systemic) that were not effective or couldn’t continue using

Participant Information

  • No cost to participate or receive study treatment
  • Regular visits with study doctors who specialise in treating eczema (15 visits)
  • Will receive either an investigative subcutaneous injection treatment (study drug) or a placebo
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • Participation will last about 81 weeks and involve about 15 visits to the study research site,

Note: Participants will need to stop all other treatments for eczema (i.e. systemic or topical medications) that could affect eczema evaluations during clinical trial participation.
Note: The investigational treatment has not been approved by Health Canada for eczema

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial